Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes.
Merlin JS, Long D, Becker WC, Cachay ER, Christopoulos KA, Claborn K, Crane HM, Edelman EJ, Harding R, Kertesz SG, Liebschutz JM, Mathews WC, Mugavero MJ, Napravnik S, C OʼCleirigh C, Saag MS, Starrels JL, Gross R. Merlin JS, et al. Among authors: saag ms. J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):77-82. doi: 10.1097/QAI.0000000000001741. J Acquir Immune Defic Syndr. 2018. PMID: 29771793 Free PMC article.
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M Jr, et al. Kappes JC, et al. Among authors: saag ms. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):139-49. doi: 10.1097/00042560-199510020-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552477 Clinical Trial.
Use of virologic markers in clinical practice.
Saag MS. Saag MS. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16 Suppl 1:S3-13. doi: 10.1097/00042560-199701001-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9389310 Review.
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS; International AIDS Society-USA. Schambelan M, et al. Among authors: saag ms. J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):257-75. doi: 10.1097/00126334-200211010-00001. J Acquir Immune Defic Syndr. 2002. PMID: 12439201 Review.
Duration of highly active antiretroviral therapy regimens.
Chen RY, Westfall AO, Mugavero MJ, Cloud GA, Raper JL, Chatham AG, Acosta EP, Taylor KH, Carter J, Saag MS. Chen RY, et al. Among authors: saag ms. Clin Infect Dis. 2003 Sep 1;37(5):714-22. doi: 10.1086/377271. Epub 2003 Aug 13. Clin Infect Dis. 2003. PMID: 12942406
Fat distribution in men with HIV infection.
Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, Saag M, Scherzer R, Shlipak M, Tien P; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Bacchetti P, et al. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):121-31. doi: 10.1097/01.qai.0000182230.47819.aa. J Acquir Immune Defic Syndr. 2005. PMID: 16186728 Free PMC article.
Distribution of health care expenditures for HIV-infected patients.
Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS. Chen RY, et al. Among authors: saag ms. Clin Infect Dis. 2006 Apr 1;42(7):1003-10. doi: 10.1086/500453. Epub 2006 Feb 22. Clin Infect Dis. 2006. PMID: 16511767
508 results